USA: Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

Drugs to prevent organ rejection are not always covered for patients who had transplants before they enrolled in Medicare.
USA: Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them? USA: Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them? Reviewed by Shahid Karimi on April 02, 2019 Rating: 5

No comments:

Powered by Blogger.